Navigation Links
Catalent Invests $5.5 Million to Increase Clinical Storage Capacity at its Philadelphia Site
Date:9/15/2017

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is investing $5.5 million at its 200,000+ square foot Philadelphia, Pennsylvania, site to provide additional clinical packaging and storage capacity.

The 22,000-square foot expansion will see a 40 percent increase in pallet space for both refrigerated and ambient storage; the addition of multiple cold chain packaging areas; and a new clinical label control area. The building will also feature a new state-of-the-art environmental monitoring and building management system which is being installed across the Philadelphia campus.

All work is scheduled to be completed and validated by November 2017.

“This project involved renovating a previously vacant building within our Philadelphia campus to bring it up to Catalent’s stringent facility standards,” commented Wetteny Joseph, Catalent’s President, Clinical Supply Services. “Not only have we added significant pallet capacity for our customers’ large-scale clinical studies today, but have secured the space necessary for future expansion as well.”

Catalent currently supports the clinical trial supply needs of many pharmaceutical and biopharmaceutical organizations, including the top 25 pharmaceutical companies, and more than 300 small innovators from all over the world. Services include direct comparator sourcing, blinding and manufacturing, primary and secondary packaging, returns and clinical supplies management.

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated over $2 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2017/09/prweb14696700.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Catalent Signs Commercial Manufacturing Agreement with US WorldMeds for Lofexidine
2. Catalent Provides Commercial Manufacturing of Lexicon Pharmaceuticals' Orphan Drug XERMELO™ Following FDA Approval
3. Catalent to Launch Innovative Fish Oil Supplement Product at Vitafoods Europe
4. Challenges and Strategies to Automate Potency Assays to be Discussed by Catalent Expert at Upcoming CASSS Bioassays Symposium
5. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
6. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
7. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
8. Catalent to Host Workshop with Leading Biologics Experts on Advanced Protein Development and Delivery at Upcoming Drug Delivery Partnerships Conference
9. Innovative Strategies for the Development of Lipid-based Oral Medicines to be Presented by Catalent and Gattefossé at Forthcoming Workshop
10. Accelerated Biopharmaceutical Development through Strategic Analytical Partnerships to be Discussed by Catalent Expert at Upcoming WCBP Conference
11. Catalent to Develop Softgel Capsules for JOT’s Leading Orphan Disease Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2019)... FALLS CHURCH, Va. (PRWEB) , ... February 19, ... ... , Critical Thinking Skills and Innovative Techniques to Improve Inspections, **Presented by FDAnews ... Early bird pricing for Conducting Advanced Root Cause Analysis CAPA Investigationsends on Feb. ...
(Date:2/19/2019)... ... February 19, 2019 , ... Renowned eye surgeon and founder ... first ever supplement to help support Keratoconus cornea health. Keratoconus is a ... supplement, KC Defense, includes specific amounts Copper (Cu) and Selenium (Se), elements that ...
(Date:2/19/2019)... WORCESTER, Mass. (PRWEB) , ... February 19, 2019 ... ... on the impact of weight stigma in pregnant and postpartum women, a team ... stigma during pregnancy and early postpartum often show increased depressive symptoms, greater weight ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... with town halls across the country , A partnership between Liberty University and ... crisis, continues with its next town hall event on Tuesday, February 19, at ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... Your House Handicap Accessible” to provide information on how-to make a house handicap ... on many different ways to make a house handicap accessible. To accurately ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Jacqueline Subka, a trusted and ... California, to make an appointment at her Simi Valley office to discuss candidacy for ... they can last 20 years or longer with proper care and restore aesthetics and ...
(Date:2/19/2019)... ... 2019 , ... TopConsumerReviews.com recently gave its best-in-class 5 star rating to Lice ... Lice outbreaks are surprisingly common, especially in schools and other environments where people come ... a sign of uncleanliness; in fact, lice prefer to live on clean hair! Getting ...
(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... Sports are ... knees – literally. That is according to a 2018 article in the British Journal ... medicine physician and orthopaedic surgeon Kevin D. Plancher, MD, MPH. , This ...
Breaking Medicine Technology: